(A) HLA alleles of patient receiving a double cord blood transplantation and of the 2 CBU infused. Patient and CBU1 present 2 mismatches in HLA-A and HLA-B loci; the mismatches at these loci occur in the HvG (HLA-A*03:01) and GvH (B*44:02) vectors, respectively, because the patient and donor are homozygous at these loci. CBU2 and the patient present only one mismatch (only in the HvG vector; A*32:01). These units present single mismatches in HLA-A in the HvG vector (A*03:01 in CBU1 and A*32:01 CBU2). (B) Evaluation of anti-HLA antibodies in the patient's serum. The patient's serum shows strong reactivity against the antigen preparation of A*32:01 present in CBU 2 and shows negligible reactivity against A*03:01 present in CBU1 and the patient's self–HLA-A antigen A*02:01. These test results indicate that CBU2 is at high risk of rejection and CBU1 is likely to engraft. Professional illustration by Paulette Dennis.

(A) HLA alleles of patient receiving a double cord blood transplantation and of the 2 CBU infused. Patient and CBU1 present 2 mismatches in HLA-A and HLA-B loci; the mismatches at these loci occur in the HvG (HLA-A*03:01) and GvH (B*44:02) vectors, respectively, because the patient and donor are homozygous at these loci. CBU2 and the patient present only one mismatch (only in the HvG vector; A*32:01). These units present single mismatches in HLA-A in the HvG vector (A*03:01 in CBU1 and A*32:01 CBU2). (B) Evaluation of anti-HLA antibodies in the patient's serum. The patient's serum shows strong reactivity against the antigen preparation of A*32:01 present in CBU 2 and shows negligible reactivity against A*03:01 present in CBU1 and the patient's self–HLA-A antigen A*02:01. These test results indicate that CBU2 is at high risk of rejection and CBU1 is likely to engraft. Professional illustration by Paulette Dennis.

Close Modal

or Create an Account

Close Modal
Close Modal